Expert consensus on integration program for cervical cancer screening and management measures for abnormal population / 医学研究生学报

ABSTRACT

Cervical cancer is a kind of malignant tumor that seriously endangers women's health. Cervical cancer has a clear etiology and easy sampling, which can be early detected by screening, and its development can be blocked by early intervention. Cervical cancer screening has been launched for rural women since 2009 in China in order to reduce the incidence of cervical cancer. However, the incidence of cervical cancer has not significantly reduced after ten years. There are three common pain points in the current cervical cancer screening program, including inaccurate sampling, invalid management and no integrated technology. The resolution of these problems will promote the development of cervical cancer screening and the establishment of the long-term mechanism of the prevention and treatment system in China. On the basis of previous studies and in combination with our innovative technologies, we put the observation function of colposcope on the first step for the screening of cervical cancer, which not only ensures accurate sampling, but also further integration of VIA/VILI, HPV typing, liquid-based cytology (TCT) and p16/ki-67 to improve the detection rate of cervical cancer and reduce false negatives. Those women in high-risk groups found by screening can be automatically followed up and given medical advices in the intelligent medical and health management platform for cervical cancer screening. Through repeatedly discussion by expert committee, we put forward expert consensus (2019) for early cervical cancer screening and abnormal crowd management in China. This expert consensus can help doctors in scientific research, clinical practice and the establishment of national policy of cervical cancer screening. We will continuously provide more data to improve cervical cancer screening process in the future.